Leverage a decision support tool designed specifically for oncologists.
In an era where the complexity of cancer care is growing exponentially, oncologists need clear, actionable insights to make the best decisions for their patients. The Perthera Report® simplifies vast amounts of data into precise ranked treatment options, empowering oncologists to choose the most effective personalized therapies.
The Perthera Report delivers ranked, detailed personalized therapy options based on your patient’s unique tumor profile, multi-omics, and medical history. This helps oncologists match patients to the cancer therapy that will deliver the best outcome.
The new Perthera Report® Pancreatic version (PRPV) includes all the Perthera Report features plus a frontline chemo predictor to dramatically improve treatment precision and patient outcomes.
Download a copy of The Perthera Report
Pancreatic version Core version2.4X
Improvement with Progression Free Survival with Perthera
A published peer-reviewed study showed that patients experienced 2.4X longer progression-free survival (PFS) when oncologists followed the Perthera Report ranked options
600+ hospitals have ordered the Perthera Report
Johns Hopkins
New York Presbyterian Hospital
Sharp Memorial Hospital
Baylor Scott & White
City of Hope
Jefferson
Mayo Clinic
MD Anderson Cancer Center
Seattle Cancer Care Alliance
University of Vermont Health Network
UVA Health
Virginia Mason Franciscan Health Logo
ONCOLOGISTS CHOOSE THE PERTHERA REPORT TO CREATE BETTER TREATMENT PLANS
01
Deliver Improved patient outcomes – 2.4 x in a recent peer reviewed study
Your patients rely on you for life-changing care. The Perthera Report provides the tools, insights, and expert support you need to deliver precision treatments that improve outcomes and quality of life. Peer-reviewed studies show the Perthera Report improves outcomes by 2.4 times. Precision insights and expert guidance lead to life-changing care and improved quality of life.
02
Collaborate with leading experts to get their treatment insights
Obtain input from top oncology specialists through the virtual Molecular Tumor Board, ensuring decisions are informed by cutting-edge expertise.
03
Simplify complex NGS testing data
The Perthera Report transforms overwhelming NGS testing data into concise, actionable insights, helping you focus on what matters most—patient care.
04
Stay ahead in a rapidly evolving field
With new therapies, research, and guidelines emerging daily, staying current is challenging. The Perthera Report keeps you informed with actionable insights grounded in the latest evidence, guidelines, and expert opinions.
05
Make confident, personalized decisions
Receive ranked, evidence-based therapy options tailored to your patient’s unique tumor profile and medical history. With clear rationales and references to support , confident decision making.
The Perthera Report Pancreatic version (PRPV) was designed for oncologists treating pancreatic cancer patients. It includes all the features of the core Perthera Report plus a frontline chemotherapy predictor.
The predictor is an AI-powered tool that provides data-driven response predictions for frontline chemotherapy in PDAC, making it a powerful decision-support tool for oncologists that can dramatically improve treatment precision and patient outcomes.